溶酶体贮积症与免疫系统。 - Suppr

Suppr

超能文献

LSDs and the immune system.

作者信息

Beck M, Vanier M

机构信息

Children's Hospital, University of Mainz, Mainz, Germany.

出版信息

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S85. doi: 10.5414/cpp47085.

DOI:10.5414/cpp47085

PMID:20040317

Abstract

摘要

相似文献

LSDs and the immune system.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S85. doi: 10.5414/cpp47085.

Perspectives from B cell immunology: fact and fancy.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S86-99. doi: 10.5414/cpp47086.

The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders.

J Inherit Metab Dis. 2016 Jul;39(4):499-512. doi: 10.1007/s10545-016-9917-1. Epub 2016 Feb 16.

Maximizing the therapeutic potential of enzyme replacement therapy for lysosomal storage diseases.

Int J Clin Pharmacol Ther. 2009 Dec;47(12):707-8. doi: 10.5414/cpp47707.

Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction.

Mol Genet Metab. 2016 Feb;117(2):66-83. doi: 10.1016/j.ymgme.2015.11.001. Epub 2015 Nov 10.

Enzyme replacement therapy for lysosomal storage diseases.

Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:26-34.

The role of antibodies in enzyme treatments and therapeutic strategies.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):183-94. doi: 10.1016/j.beem.2015.01.006. Epub 2015 Jan 24.

Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.

Pediatr Ann. 2018 May 1;47(5):e191-e197. doi: 10.3928/19382359-20180424-01.

Advances in Immune Tolerance Induction in Enzyme Replacement Therapy.

Paediatr Drugs. 2024 May;26(3):287-308. doi: 10.1007/s40272-024-00627-9. Epub 2024 Apr 25.

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Nat Biotechnol. 2008 Aug;26(8):901-8. doi: 10.1038/nbt.1484.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

LSDs and the immune system.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S85. doi: 10.5414/cpp47085.

Perspectives from B cell immunology: fact and fancy.

Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S86-99. doi: 10.5414/cpp47086.

The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders.

J Inherit Metab Dis. 2016 Jul;39(4):499-512. doi: 10.1007/s10545-016-9917-1. Epub 2016 Feb 16.

Maximizing the therapeutic potential of enzyme replacement therapy for lysosomal storage diseases.

Int J Clin Pharmacol Ther. 2009 Dec;47(12):707-8. doi: 10.5414/cpp47707.

Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction.

Mol Genet Metab. 2016 Feb;117(2):66-83. doi: 10.1016/j.ymgme.2015.11.001. Epub 2015 Nov 10.

Enzyme replacement therapy for lysosomal storage diseases.

Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:26-34.

The role of antibodies in enzyme treatments and therapeutic strategies.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):183-94. doi: 10.1016/j.beem.2015.01.006. Epub 2015 Jan 24.

Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.

Pediatr Ann. 2018 May 1;47(5):e191-e197. doi: 10.3928/19382359-20180424-01.

Advances in Immune Tolerance Induction in Enzyme Replacement Therapy.

Paediatr Drugs. 2024 May;26(3):287-308. doi: 10.1007/s40272-024-00627-9. Epub 2024 Apr 25.

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Nat Biotechnol. 2008 Aug;26(8):901-8. doi: 10.1038/nbt.1484.